M13

Activity from announced rounds

Activity in this selectionAI

M13 is the venture organization whose portfolio identifies Ayble Health and which OpenFX names in its Series A.

Recorded funding activity

Ayble supplies virtual digestive care. Rime develops conversational speech models, while Chord supplies commerce software. These company financings preserve distinct customer problems under the same firm identity.

Sources
Rounds participated in
3
Confirmed lead rounds
1
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$66M
3 disclosed · full round size, not this investor’s share

By stage

Series A2
Undisclosed1

By primary sector

AI2
Fintech1

By country

United States3

Rounds

3 in this selection
Baselayer

Baselayer helps banks, lenders and payments companies verify businesses and assess identity, credit and fraud risk.

$35MSeries A
Lead
Rime

Rime develops conversational speech models for enterprise voice-AI applications.

$24MSeries A
Role not disclosed
Chord

Provides AI platform for modern commerce operations

$7MUndisclosed
Role not disclosed